Anticancer agent 43
Based on 1 Customer Validation
Anticancer Agent 43 is a potent anticancer agent. Anticancer Agent 43 induces apoptosis by caspase 3, PARP1, and Bax dependent mechanisms. Anticancer Agent 43 induces DNA damage.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 98.58%
- CAS No.: 2470015-35-9
- Formule: C14H9FN2O3S2
- Masse moléculaire:336.36
-
Stockage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Voir tous les produits spécifiques à Isoform Caspase
More
Activité biologique
Description
IC50 & Target
[1]|
Caspase 3 |
PARP1 |
Bax |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | GI50 |
9.7 μM
Compound: 3a
|
Cytotoxicity against human A549 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay
|
[PMID: 34634616] |
| BALB/3T3 | GI50 |
>100 μM
Compound: 3a
|
Cytotoxicity against mouse BALB/3T3 cells assessed as cell growth inhibition measured after 24 hrs by coomassie brilliant blue staining based total cellular protein assay
Cytotoxicity against mouse BALB/3T3 cells assessed as cell growth inhibition measured after 24 hrs by coomassie brilliant blue staining based total cellular protein assay
|
[PMID: 34634616] |
| BALB/3T3 | GI50 |
>100 μM
Compound: 3a
|
Cytotoxicity against mouse BALB/3T3 cells assessed as cell growth inhibition measured after 24 hrs by LDH assay
Cytotoxicity against mouse BALB/3T3 cells assessed as cell growth inhibition measured after 24 hrs by LDH assay
|
[PMID: 34634616] |
| BALB/3T3 | GI50 |
>100 μM
Compound: 3a
|
Cytotoxicity against mouse BALB/3T3 cells assessed as cell growth inhibition measured after 24 hrs by neutral red uptake assay
Cytotoxicity against mouse BALB/3T3 cells assessed as cell growth inhibition measured after 24 hrs by neutral red uptake assay
|
[PMID: 34634616] |
| BALB/3T3 | GI50 |
>100 μM
Compound: 3a
|
Cytotoxicity against mouse BALB/3T3 cells assessed as cell growth inhibition measured after 48 hrs by coomassie brilliant blue staining based total cellular protein assay
Cytotoxicity against mouse BALB/3T3 cells assessed as cell growth inhibition measured after 48 hrs by coomassie brilliant blue staining based total cellular protein assay
|
[PMID: 34634616] |
| BALB/3T3 | GI50 |
>100 μM
Compound: 3a
|
Cytotoxicity against mouse BALB/3T3 cells assessed as cell growth inhibition measured after 48 hrs by neutral red uptake assay
Cytotoxicity against mouse BALB/3T3 cells assessed as cell growth inhibition measured after 48 hrs by neutral red uptake assay
|
[PMID: 34634616] |
| BALB/3T3 | GI50 |
25 μM
Compound: 3a
|
Cytotoxicity against mouse BALB/3T3 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
Cytotoxicity against mouse BALB/3T3 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
|
[PMID: 34634616] |
| BALB/3T3 | GI50 |
40.8 μM
Compound: 3a
|
Cytotoxicity against mouse BALB/3T3 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay
Cytotoxicity against mouse BALB/3T3 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay
|
[PMID: 34634616] |
| BALB/3T3 | GI50 |
48.3 μM
Compound: 3a
|
Cytotoxicity against mouse BALB/3T3 cells assessed as cell growth inhibition measured after 72 hrs by coomassie brilliant blue staining based total cellular protein assay
Cytotoxicity against mouse BALB/3T3 cells assessed as cell growth inhibition measured after 72 hrs by coomassie brilliant blue staining based total cellular protein assay
|
[PMID: 34634616] |
| BALB/3T3 | GI50 |
51.5 μM
Compound: 3a
|
Cytotoxicity against mouse BALB/3T3 cells assessed as cell growth inhibition measured after 72 hrs by neutral red uptake assay
Cytotoxicity against mouse BALB/3T3 cells assessed as cell growth inhibition measured after 72 hrs by neutral red uptake assay
|
[PMID: 34634616] |
| BALB/3T3 | GI50 |
54.3 μM
Compound: 3a
|
Cytotoxicity against mouse BALB/3T3 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay
Cytotoxicity against mouse BALB/3T3 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay
|
[PMID: 34634616] |
| BALB/3T3 | GI50 |
62.8 μM
Compound: 3a
|
Cytotoxicity against mouse BALB/3T3 cells assessed as cell growth inhibition measured after 72 hrs by LDH assay
Cytotoxicity against mouse BALB/3T3 cells assessed as cell growth inhibition measured after 72 hrs by LDH assay
|
[PMID: 34634616] |
| BALB/3T3 | GI50 |
89.7 μM
Compound: 3a
|
Cytotoxicity against mouse BALB/3T3 cells assessed as cell growth inhibition measured after 48 hrs by LDH assay
Cytotoxicity against mouse BALB/3T3 cells assessed as cell growth inhibition measured after 48 hrs by LDH assay
|
[PMID: 34634616] |
| HaCaT | GI50 |
98.3 μM
Compound: 3a
|
Cytotoxicity against human HaCaT cells assessed as cell growth inhibition measured after 72 hrs by MTT assay
Cytotoxicity against human HaCaT cells assessed as cell growth inhibition measured after 72 hrs by MTT assay
|
[PMID: 34634616] |
| HCT-116 | GI50 |
0.8 μM
Compound: 3a
|
Cytotoxicity against human HCT-116 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay
Cytotoxicity against human HCT-116 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay
|
[PMID: 34634616] |
| HeLa | GI50 |
49.3 μM
Compound: 3a
|
Cytotoxicity against human HeLa cells assessed as cell growth inhibition measured after 72 hrs by MTT assay
Cytotoxicity against human HeLa cells assessed as cell growth inhibition measured after 72 hrs by MTT assay
|
[PMID: 34634616] |
| HepG2 | GI50 |
>100 μM
Compound: 3a
|
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 24 hrs by coomassie brilliant blue staining based total cellular protein assay
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 24 hrs by coomassie brilliant blue staining based total cellular protein assay
|
[PMID: 34634616] |
| HepG2 | GI50 |
0.04 μM
Compound: 3a
|
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 72 hrs by LDH assay
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 72 hrs by LDH assay
|
[PMID: 34634616] |
| HepG2 | GI50 |
0.06 μM
Compound: 3a
|
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 48 hrs by LDH assay
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 48 hrs by LDH assay
|
[PMID: 34634616] |
| HepG2 | GI50 |
0.31 μM
Compound: 3a
|
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 24 hrs by LDH assay
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 24 hrs by LDH assay
|
[PMID: 34634616] |
| HepG2 | GI50 |
12.1 μM
Compound: 3a
|
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay
|
[PMID: 34634616] |
| HepG2 | GI50 |
16.3 μM
Compound: 3a
|
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
|
[PMID: 34634616] |
| HepG2 | GI50 |
24.5 μM
Compound: 3a
|
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 48 hrs by neutral red uptake assay
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 48 hrs by neutral red uptake assay
|
[PMID: 34634616] |
| HepG2 | GI50 |
35.6 μM
Compound: 3a
|
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 72 hrs by coomassie brilliant blue staining based total cellular protein assay
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 72 hrs by coomassie brilliant blue staining based total cellular protein assay
|
[PMID: 34634616] |
| HepG2 | GI50 |
40.1 μM
Compound: 3a
|
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 24 hrs by neutral red uptake assay
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 24 hrs by neutral red uptake assay
|
[PMID: 34634616] |
| HepG2 | GI50 |
44.7 μM
Compound: 3a
|
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay
|
[PMID: 34634616] |
| HepG2 | GI50 |
63.9 μM
Compound: 3a
|
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 48 hrs by coomassie brilliant blue staining based total cellular protein assay
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 48 hrs by coomassie brilliant blue staining based total cellular protein assay
|
[PMID: 34634616] |
| HepG2 | GI50 |
7.5 μM
Compound: 3a
|
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 72 hrs by neutral red uptake assay
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 72 hrs by neutral red uptake assay
|
[PMID: 34634616] |
| MCF7 | GI50 |
0.7 μM
Compound: 3a
|
Cytotoxicity against human MCF7 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay
|
[PMID: 34634616] |
| THP-1 | GI50 |
62.4 μM
Compound: 3a
|
Cytotoxicity against human THP-1 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay
Cytotoxicity against human THP-1 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay
|
[PMID: 34634616] |
| WM793 | GI50 |
80.4 μM
Compound: 3a
|
Cytotoxicity against human WM793 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay
Cytotoxicity against human WM793 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay
|
[PMID: 34634616] |
In Vitro
Anticancer agent 43 (compound 3a) shows selectivity toward human tumor cells (SI50=28.94)[1].
Anticancer agent 43 (45 µM, 24 h) induces apoptosis via caspase 3, PARP1 and Bax dependent pathways in HepG2 cells[1].
Anticancer agent 43 (45 µM, 24 h) shows no effect on the transition of G1/S phases in HepG2 cells[1].
Anticancer agent 43 (0.7, 45, 55 µM) induces DNA damage in HCT116 cells (Tail DNA=16.1%, OTM=3.7), MCF-7 cells, HepG2 cells (Tail DNA=26.2%, OTM=13.2), Balb/c 3T3 cells (Tail DNA = 8.4%, OTM = 3.5)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HepG2, MCF-7, HCT116, HeLa, A549, WM793, THP-1, HaCaT, Balb/c3T3 cells
-
Concentration:0, 1, 10, 100 µM
-
Incubation Time:72 h
-
Result:Showed cytotoxic action with GI50s of 12.1, 0.7, 0.8, 49.3, 9.7 µM for for HepG2, MCF-7, HCT116, HeLa, A549 cells, low toxicity towards WM793, THP-1, HaCaT, Balb/c 3T3 cells with GI50s of 80.4, 62.4,98.3,40.8 µM , respectively.
-
Cell Line:HepG2 cells
-
Concentration:45 µM
-
Incubation Time:24 h
-
Result:Induced apoptosis in HepG2 cells via caspase 3, PARP1 and Bax dependent pathways.
-
Cell Line:HCT116, MCF-7 cells
-
Concentration:0.7 µM
-
Incubation Time:24 h
-
Result:Decreased the expression of Cdk2 protein in HCT116 and MCF-7 cells.
-
Cell Line:HepG2 cells
-
Concentration:45 µM
-
Incubation Time:24 h
-
Result:Showed no effect on the transition of G1/S phases in HepG2 cells.
Chemical Information
-
CAS No. 2470015-35-9
-
Appearance Solid
-
Masse moléculaire 336.36
-
Formule C14H9FN2O3S2
-
Color Light yellow to yellow
-
SMILES
COC(C1=C(C2=C(N1)C=CC(F)=C2)/C=C3SC(NC\3=O)=S)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Solvant et solubilité
In Vitro:
DMSO : 125 mg/mL (371.63 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Protocole
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Genotoxicity/Mutagenicity Study
The bacterial reverse mutation assay detects point mutations that restore amino-acid prototrophy in auxotrophic Salmonella typhimurium or Escherichia coli tester strains; after exposure to a test article, mutagenic activity is read out as an increased number of revertant colonies on minimal agar compared with the vehicle control. The assay uses tester strains with different mutation targets so that base-substitution and frameshift mutagens can be detected, and testing is performed with and without exogenous mammalian metabolic activation because some chemicals require biotransformation to become mutagenic.
Pureté et documentation
-
Fiche technique (282 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Instruction de manipulation (2659 KB)
Références
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.9730 mL | 14.8650 mL | 29.7301 mL | 74.3251 mL |
| 5 mM | 0.5946 mL | 2.9730 mL | 5.9460 mL | 14.8650 mL | |
| 10 mM | 0.2973 mL | 1.4865 mL | 2.9730 mL | 7.4325 mL | |
| 15 mM | 0.1982 mL | 0.9910 mL | 1.9820 mL | 4.9550 mL | |
| 20 mM | 0.1487 mL | 0.7433 mL | 1.4865 mL | 3.7163 mL | |
| 25 mM | 0.1189 mL | 0.5946 mL | 1.1892 mL | 2.9730 mL | |
| 30 mM | 0.0991 mL | 0.4955 mL | 0.9910 mL | 2.4775 mL | |
| 40 mM | 0.0743 mL | 0.3716 mL | 0.7433 mL | 1.8581 mL | |
| 50 mM | 0.0595 mL | 0.2973 mL | 0.5946 mL | 1.4865 mL | |
| 60 mM | 0.0496 mL | 0.2478 mL | 0.4955 mL | 1.2388 mL | |
| 80 mM | 0.0372 mL | 0.1858 mL | 0.3716 mL | 0.9291 mL | |
| 100 mM | 0.0297 mL | 0.1487 mL | 0.2973 mL | 0.7433 mL |